The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorCephas Health Research Initiative Inc, Ibadan, Nigeria
About this trial
This randomized controlled trial evaluates whether exposure to a medical television drama improves knowledge of neurocysticercosis (NCC) among young adults. Sixty participants aged 18-35 will be randomly assigned to either an intervention group, which will watch a medically relevant TV episode (House M.D., Season 1, Episode 1), or a control group with no media exposure. Both groups will complete pre- and post-test questionnaires assessing knowledge of NCC. The primary outcome is change in NCC-related knowledge. Secondary outcomes include motivation to seek further health information and perceived credibility of the media source
Eligibility criteria
Qualifiers
Aged 18 to 35 years
Proficient in English (reading and comprehension)
Has access to a stable internet connection
Possesses a screen-enabled device (e.g., smartphone, tablet, or computer)
Disqualifiers
Has formal education in medical or health sciences
Has a prior diagnosis of neurocysticercosis (NCC)
Has previously participated in any NCC-related health literacy or awareness program
Lacks access to the Netflix movie platform
Trial design
Treatments tested in this trial
- Medical TV Drama Episode (House M.D.)
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov